Page 89 - Read Online

Zeng et al. Cancer Drug Resist 2024;7:31 https://dx.doi.org/10.20517/cdr.2024.57 Page 13 of 13

study. Lancet 2019;393:156-67. DOI PubMed
83. Han J, Zakeri K, Raab G, et al. Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck
cancer. Head Neck 2023;45:2207-16. DOI PubMed PMC
84. Alexa-Stratulat T, Pešić M, Gašparović AČ, Trougakos IP, Riganti C. What sustains the multidrug resistance phenotype beyond ABC
efflux transporters? Looking beyond the tip of the iceberg. Drug Resist Updat 2019;46:100643. DOI PubMed
85. Vasan N, Baselga J, Hyman DM. A view on drug resistance in cancer. Nature 2019;575:299-309. DOI PubMed PMC
86. Huang A, Zheng H, Wu Z, Chen M, Huang Y. Circular RNA-protein interactions: functions, mechanisms, and identification.
Theranostics 2020;10:3503-17. DOI PubMed PMC
87. Hong X, Liu N, Liang Y, et al. Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and
docetaxel chemoresistance through upregulating FOXQ1. Mol Cancer 2020;19:33. DOI PubMed PMC
88. Liu L, Lu B, Li Y. Circular RNA circ_0008450 regulates the proliferation, migration, invasion, apoptosis and chemosensitivity of
CDDP-resistant nasopharyngeal carcinoma cells by the miR-338-3p/SMAD5 axis. Anticancer Drugs 2022;33:e260-72. DOI
PubMed
89. Hong X, Li Q, Li J, et al. CircIPO7 promotes nasopharyngeal carcinoma metastasis and cisplatin chemoresistance by facilitating
YBX1 nuclear localization. Clin Cancer Res 2022;28:4521-35. DOI PubMed
90. Cheng Y, Zhu Y, Xiao M, et al. circRNA_0067717 promotes paclitaxel resistance in nasopharyngeal carcinoma by acting as a
scaffold for TRIM41 and p53. Cell Oncol 2023;46:677-95. DOI PubMed
91. Ai J, Tan G, Li W, et al. Exosomes loaded with circPARD3 promotes EBV-miR-BART4-induced stemness and cisplatin resistance in
nasopharyngeal carcinoma side population cells through the miR-579-3p/SIRT1/SSRP1 axis. Cell Biol Toxicol 2023;39:537-56. DOI
PubMed
92. Qiongna D, Jiafeng Z, Yalin H, et al. Implication of hsa_circ_0028007 in reinforcing migration, invasion, and chemo-tolerance of
nasopharyngeal carcinoma cells. J Clin Lab Anal 2020;34:e23409. DOI PubMed PMC
93. Lin J, Qin H, Han Y, Li X, Zhao Y, Zhai G. CircNRIP1 modulates the miR-515-5p/IL-25 axis to control 5-Fu and cisplatin resistance
in nasopharyngeal carcinoma. Drug Des Devel Ther 2021;15:323-30. DOI PubMed PMC
94. Feng B, Chen K, Zhang W, Zheng Q, He Y. circPGAM1 enhances autophagy signaling during laryngocarcinoma drug resistance by
regulating miR-376a. Biochem Biophys Res Commun 2021;534:966-72. DOI PubMed
95. Yi X, Chen W, Li C, et al. Circular RNA circ_0004507 contributes to laryngeal cancer progression and cisplatin resistance by
sponging miR-873 to upregulate multidrug resistance 1 and multidrug resistance protein 1. Head Neck 2021;43:928-41. DOI
PubMed
96. Wu S, Lv X, Wei H, et al. Circ-ILF2 in oral squamous cell carcinoma promotes cisplatin resistance and induces M2 polarization of
macrophages. J Cell Mol Med 2023;27:4133-44. DOI PubMed PMC
97. Ren W, Cheng Y, Li S, Zheng J, Gao L, Zhi K. circAP1M2 activates ATG9A-associated autophagy by inhibiting miR-1249-3p to
promote cisplatin resistance in oral squamous cell carcinoma. J Cell Physiol 2023;238:2612-24. DOI PubMed
98. Gao F, Han J, Wang Y, Jia L, Luo W, Zeng Y. Circ_0109291 promotes cisplatin resistance of oral squamous cell carcinoma by
sponging miR-188-3p to increase ABCB1 expression. Cancer Biother Radiopharm 2022;37:233-45. DOI PubMed
99. Yan J, Xu H. Regulation of transforming growth factor-beta1 by circANKS1B/miR-515-5p affects the metastatic potential and
cisplatin resistance in oral squamous cell carcinoma. Bioengineered 2021;12:12420-30. DOI PubMed PMC
100. Su M, Xiao Y, Ma J, et al. Circular RNAs in Cancer: emerging functions in hallmarks, stemness, resistance and roles as potential
biomarkers. Mol Cancer 2019;18:90. DOI PubMed PMC